Sphere Bio

Sphere Bio (formerly known as Sphere Fluidics) became a brand of Fluidic Sciences Ltd following the acquisition of its business and assets in September 2025. The original company was founded as a Cambridge-based Life Sciences R&D company specializing in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation. The company's reported 25 patented products encompassing picodroplet-based microfluidic instruments Cyto-Mine and Cyto-Mine Chroma, biochips, and specialist chemicals was also transferred to Fluidic Sciences Ltd as part of the acquisition.